QA: Paratek Pharmaceuticals Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001178711_2023_Paratek_Pharmaceuticals_Inc.pdf

Logs

info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001178711')"}

Graph

Absolute values for 0001178711, Paratek Pharmaceuticals Inc.

  xvar xval
0 AssetsCurrent 136,842,000
1 IntangibleAssetsNetIncludingGoodwill 829,000
2 PropertyPlantAndEquipmentNet 616,000
3 remainder_Assets 34,251,000
4 LiabilitiesCurrent 37,388,000
5 LiabilitiesNoncurrent 260,867,000
6 remainder_Liabilities 45,325,000
7 CostOfGoodsAndServicesSold 23,056,000
8 SellingGeneralAndAdministrativeExpense 145,598,000
9 ResearchAndDevelopmentExpense 37,823,000
10 remainder_Expenses 18,176,000
11 remainder_Revenues 160,268,000
12 remainder_NetIncome 819,000
13 remainder_ComprehensiveNetIncome 9,000
  yvar yval
0 Assets 172,538,000
1 Liabilities 343,580,000
2 Expenses 224,653,000
3 Revenues 160,268,000
4 StockholdersEquity -171,042,000
5 NetIncome -63,566,000
6 ComprehensiveNetIncome -63,561,500
7 BaseVar 450,933,500
8 EconomicCapitalRatio -1.39

Edgar->Model Mapping

Feature Distribution

Change over Time